Literature DB >> 30878952

Lanthanum phosphate binder-induced iron deficiency anaemia.

Christina Awad1, Karin Gilkison2, Erwin Shaw2.   

Abstract

Lanthanum carbonate is a phosphate binder that is used to reduce serum phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum forms insoluble lanthanum phosphate complexes that are supposed to pass through the gastrointestinal (GI) tract unabsorbed. Phosphate binders have been reported to deposit in the GI tract and can cause mucosal injury. There are few case reports of GI bleeding associated with phosphate binder deposits. This case report presents a patient with iron deficiency anaemia secondary to biopsy-proven lanthanum deposits in the upper GI tract. There were no overt signs of active GI bleeding. Patient's anaemia improved with discontinuation of the phosphate binder. Lanthanum could be a hidden cause of resistant anaemia among patients with ESRD through asymptomatic GI blood loss. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Gi bleeding; drugs: gastrointestinal system; gastrointestinal system; oesophagus; ulcer

Mesh:

Substances:

Year:  2019        PMID: 30878952      PMCID: PMC6424195          DOI: 10.1136/bcr-2018-226157

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Gastrointestinal Nodules and Bleeding with Long-Term Lanthanum Use; DRESS and Hepatotoxicity Due to Rivaroxaban; Thrombocytopenia Induced by Pentoxifylline; Amlodipine-Induced Schamberg's Disease; Varenicline-Induced Acute Liver Injury.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2016-04

2.  Gastric mucosal status susceptible to lanthanum deposition in patients treated with dialysis and lanthanum carbonate.

Authors:  Shinichi Ban; Syunji Suzuki; Kenji Kubota; Susumu Ohshima; Hideaki Satoh; Hiroki Imada; Yoshihiko Ueda
Journal:  Ann Diagn Pathol       Date:  2016-10-05       Impact factor: 2.090

3.  Extensive lanthanum deposition in the gastric mucosa: the first histopathological report.

Authors:  Mutsuki Makino; Kenji Kawaguchi; Hisashi Shimojo; Hironori Nakamura; Masaki Nagasawa; Ryo Kodama
Journal:  Pathol Int       Date:  2014-11-20       Impact factor: 2.534

4.  Clinical Characteristics of Seven Patients with Lanthanum Phosphate Deposition in the Stomach.

Authors:  Naoko Murakami; Masao Yoshioka; Masaya Iwamuro; Junichirou Nasu; Soichiro Nose; Junji Shiode; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

5.  Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis.

Authors:  Jared Magee; Matthew Robles; Peter Dunaway
Journal:  Case Rep Gastroenterol       Date:  2018-02-01

6.  Gastrointestinal complications induced by sevelamer crystals.

Authors:  Claudia Yuste; Evangelina Mérida; Eduardo Hernández; Ana García-Santiago; Yolanda Rodríguez; Teresa Muñoz; Gonzalo Jesús Gómez; Ángel Sevillano; Manuel Praga
Journal:  Clin Kidney J       Date:  2017-04-10
  6 in total
  1 in total

Review 1.  Review of the diagnosis of gastrointestinal lanthanum deposition.

Authors:  Masaya Iwamuro; Haruo Urata; Takehiro Tanaka; Hiroyuki Okada
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.